IRIS
MARCHESONI, Diego
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.128
AS - Asia 10.498
EU - Europa 9.248
SA - Sud America 1.777
AF - Africa 269
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 20
AN - Antartide 1
Totale 44.962
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.755
SG - Singapore 5.228
UA - Ucraina 2.390
CN - Cina 2.056
DE - Germania 1.708
IT - Italia 1.488
BR - Brasile 1.413
HK - Hong Kong 1.007
FI - Finlandia 990
VN - Vietnam 682
RU - Federazione Russa 610
FR - Francia 576
IE - Irlanda 374
SE - Svezia 369
IN - India 335
GB - Regno Unito 319
TR - Turchia 257
CA - Canada 242
KR - Corea 189
BD - Bangladesh 165
AR - Argentina 140
PL - Polonia 83
IQ - Iraq 75
MX - Messico 75
ZA - Sudafrica 75
JP - Giappone 70
CZ - Repubblica Ceca 65
IR - Iran 62
ID - Indonesia 50
VE - Venezuela 50
EC - Ecuador 49
MA - Marocco 48
BE - Belgio 45
NL - Olanda 44
PK - Pakistan 40
CO - Colombia 38
SA - Arabia Saudita 35
UZ - Uzbekistan 34
EG - Egitto 31
AT - Austria 27
ES - Italia 27
PH - Filippine 26
CL - Cile 23
TG - Togo 23
EU - Europa 21
PY - Paraguay 20
AE - Emirati Arabi Uniti 19
AZ - Azerbaigian 19
KE - Kenya 18
TN - Tunisia 18
AU - Australia 17
CH - Svizzera 17
MY - Malesia 16
NP - Nepal 15
JO - Giordania 14
PE - Perù 14
UY - Uruguay 14
BO - Bolivia 13
DZ - Algeria 13
ET - Etiopia 13
PT - Portogallo 13
RS - Serbia 13
IL - Israele 12
JM - Giamaica 12
LT - Lituania 12
BG - Bulgaria 11
RO - Romania 11
KG - Kirghizistan 10
OM - Oman 10
TH - Thailandia 10
PS - Palestinian Territory 9
GR - Grecia 8
AL - Albania 7
CR - Costa Rica 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
LB - Libano 6
PA - Panama 6
AO - Angola 5
HN - Honduras 5
HR - Croazia 5
KZ - Kazakistan 5
MN - Mongolia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BH - Bahrain 4
DK - Danimarca 4
EE - Estonia 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
BA - Bosnia-Erzegovina 3
LI - Liechtenstein 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
BB - Barbados 2
Totale 44.909
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.304
Singapore 2.255
Ann Arbor 2.056
Chandler 1.854
Jacksonville 1.673
Ashburn 1.416
Houston 1.402
Fairfield 1.163
Hong Kong 994
Beijing 983
Dearborn 978
San Jose 912
Wilmington 646
Boardman 489
Munich 450
Princeton 394
Dublin 373
Seattle 373
Lauterbourg 343
Los Angeles 332
Cambridge 319
Helsinki 294
New York 292
Hefei 232
Ho Chi Minh City 226
Buffalo 202
Dallas 201
Izmir 189
Seoul 175
Udine 170
The Dalles 161
Sacile 157
Des Moines 142
Hanoi 141
San Diego 131
São Paulo 130
Council Bluffs 126
Ottawa 114
Grafing 99
Ogden 98
Norwalk 88
Redondo Beach 87
Mumbai 84
Frankfurt am Main 69
Nanjing 68
Turku 68
Milan 66
Tokyo 66
Orem 65
Monmouth Junction 63
Kunming 60
Santa Clara 55
Warsaw 54
Brno 53
Atlanta 51
Leawood 50
Montreal 44
Rio de Janeiro 44
Trieste 44
San Mateo 43
Toronto 43
Brussels 40
Jinan 40
Düsseldorf 39
London 36
Ardabil 35
Simi Valley 34
Chennai 33
Guangzhou 33
Rome 33
Brooklyn 32
Stockholm 32
Augusta 30
Belo Horizonte 30
Tashkent 30
Denver 29
Haiphong 29
Washington 29
Johannesburg 28
Baghdad 27
Résia 27
Chicago 26
Nuremberg 26
Phoenix 25
Brasília 24
Da Nang 24
Lomé 23
Boston 22
Dhaka 22
Guayaquil 22
Porto Alegre 22
Redwood City 22
San Francisco 22
Mexico City 21
Nanchang 21
Biên Hòa 20
Mcallen 20
Portsmouth 20
Shenyang 20
Amsterdam 19
Totale 27.321
Salva come PNG Salva come JPEG
Nome #
Comparison between bidimensional sonography and three dimensional power Doppler angiography (VOCALTM) for assessment of fetal renal blood flow in normal gestation 294
Comparision between Bidimensional Sonography and 3-Dimensional Power Doppler Angiography (Virtual Organ Computer-Aided Analysis) for Assessment of fetal renal blood flow in Normal Gestation 276
Comparision between Bidimensional Sonography and 3-dimensional Power Doppler Angiography (VOCAL) for Assessment of Fetal Renal Blood Flow in Normal Gestation 275
Drugs and pregnancy: 5 year experience at the Teratologic Service of the Azienda Ospedaliero- Universitaria of Udine. 253
Gynaecological cancer management at the end of 20th century 249
INDUZIONE DELLA MATURAZIONE POLMONARE FETALE NELLA PROFILASSI DELLA MALATTIA DA MEMBRANE IALINE E SEPSI NEONATALE 226
Sindrome uremico emolitica nel post partum, paziente affetta da sdr. HELLP. Case report. 213
Retinol binding protein as early marker of fetal growth restriction in first trimester maternal serum. 212
A retrospective cohort study of the association of parity with urinary incontinence - Does the multiparity select an urinary incontinence resistant cohort? 204
Acute promyelocytic leukemia during pregnancy 200
A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS) 196
CPR2 as a new Doppler parameter for assessment of wellbeing in fetal growth restricted fetuses 195
Assessment of endometrial volume and vascularization using transvaginal 3D power Doppler angiography in women with postmenopausal bleeding. 195
Puerperal ovarian vein thrombosis: two case reports 193
Survivin, MMP-2, MT1-MMP, and TIMP-2: their impact on survival, implantation, and proliferation of endometriotic tissues 193
Assessment of fetale brain vascularization in fetal growth restriction comparing three-dimensional power angiography to bi-dimensional velocimetry 192
Biochimica dello scatchard plot: vantaggi della competizione 190
Body mass index, life style characteristics and post-menopausal symptoms 187
A new proposal of sonobiopsy of fetal brain using 3D power Doppler angiography (VOCAL) in normal and growth restricted fetuses 187
Second trimester maternal plasma and amniotic fluid adipokines in women who will develop gestational diabetes mellitus 187
Assessment of Fetal Brain Vascularization using Three-Dimensional Power Doppler Ultrasound Angiography in Pregnancies Affected by Fetal Growth Restriction 185
Bone ultrasonometry measurements during pregnancy 184
Three dimensional cerebroplacental ratio (CPR 3DPDA): a proposal of a new prameter for the antenatal surveillance in IUGR fetuses 182
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 181
Diagnostic value of endometrial volume and vascular indices by 3D ultrasonography power Doppler angiography (3D-PDA) in patients with postmenopausal bleeding 179
Ischemia modified albumin in pregnancy 178
Amniotic Band syndrome 177
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 174
Incomplete pentalogy of Cantrell during first trimester of pregnancy: case report 174
Ischemia modified Albumin in Pregnancy 173
Building a Prediction Model for Vacuum-Assisted Operative Vaginal Delivery Risk 172
Fetal gender ratio in recurrent miscarriages 172
Modificazioni cardiovascolari materne in gravidanza 169
A screening program for endometrial cancer in an asymptomatic postmenopausal population in our City: Preliminary data 168
Valutazione dell'efficacia predittiva del modello di Gail nel calcolo del rischio di carcinoma della mammella 168
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 167
Identification of risk factors and the use of quantitative ultrasounds (QUS) in order to select high risk of fracture women over 40 years old. Is osteoporosis screeening possible) 167
Aplasia cutis congenita and vanishing twin syndrome 166
Combinated management of heterotopic Cesarean scar pregnancy 164
Near-miss and maternal mortality in a tertiary care facility in Italy 163
Chorangioma and Fetal Anemia: A Case Report 163
Valutazione prospettica di un test di screening combinato per la sindrome di Down presso il Centro di diagnosi prenatale della Clinica Ostetrica di Udine 161
Parto-analgesia and post-partum blood loss 160
A Metabolomic Approach to Selective Intrauterine Growth Restriction (sIUGR) in Monochorionic Pregnancies 160
High placental index and poor pregnancy outcomes: a retrospective study of 18,386 pregnancies. 160
Identification of patients with a high risk of osteoporosis. Analysis of risk factors, ultrasonography and DEXA, in a female population in the North East of Italy 157
Lo screening della traslucenza nucale fetale: i risultati e la corretta comunicazione del test 156
Oxidized Transthyretin in amniotic fluid as an early marker of preeclampsia 156
Ultrasonographic assessment of cervix size and its correlation with female characteristics, pregnancy, BMI, and other anthropometric features 156
Ischemia modified albumin in pregnancy 156
Sonobiopsia fetale cerebrale mediante angiografia tridimensionale power Doppler in feti normali e IUGR: una nuova proposta 155
Feto-maternal outcome, epidural analgesia, and fetal occiput-posterior position 154
Analisi retrospettiva su un anno di tagli cesarei: indicazioni e fattori di rischio per taglio cesareo in travaglio di parto [Retrospective analysis of one year of cesarean sections: indications and risk factors associated with intrapartum cesarean section] 154
Evaluation of fetal cerebral blood flow perfusion using power Doppler ultrasound angiography (3D_PDA) in normal and growth-restricted fetuses (IUGR) 153
Placenta percreta with bladder invasion. 153
RISK FACTORS FOR TYPE 2 DIABETES IN WOMEN ATTENDING MENOPAUSE CLINICS IN ITALY: A CROSS-SECTIONAL STUDY 153
24-Hour ambulatory blood pressure monitoring in smoker and non smoker post-menopuasal women treated with ERT 153
Metabolismo placentare e PAPP-A: studio prospettico sul ruolo del PAPP-A tra la 11° e la 13a settimana piu’ sei giorni di gestazione per valutare la funzionalità placentare 152
Gynaecological aspects of primary Sjogren's syndrome 152
Maternal cardiac haemodinamic changes during physiological pregnancy and psot-partum period 151
Cerebro Placental Ratio 2: a new Doppler parameter to assess the well being of the fetus 149
The diagnostic value of endometrial volume and vascularity measurement by transvaginal three–dimensional ultrasonography and Power Doppler angiography in patients with postmenopausal bleeding 149
The Pelvic Masses Score (PMS): a proposed new scoring system to evaluate pelvic masses 149
Climaterium ad an oncologic risk factor 148
Intrahepatic cholestatis of pregnancy; a in vivo model of the hepatic clearance of adiponectin 148
Twin ectopic pregnancy in a previous cesarean scar section and subsequent fertility 148
Ischemia - modified albumin in pregnancy 148
Fibrinolisi nel carcinoma ovarico 147
[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature] 147
Anthropometric factors and reproductive history of a population of young women affected by benign breast disease 147
Prepregnancy body mass index and adverse pregnancy outcomes 147
Measurement of fetal urine production using trhee dimensional ultrasonography rotational technique (VOCALTM) in normal pregnancy 146
Ductus Venosus S-wave/isovolumetric A-wave (SIA) Index and A-Wave reversed flow in normal gestation 146
Assessment of Fetal Brain Vascularization using Three-Dimensional Power Doppler Ultrasound Angiography in Pregnancies affected by Fetal Growth Restriction 146
Therapy side-effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour. 145
A woman presenting rheumatic cardiopathy in pregnancy: a case report 145
Breast-feeding and benign breast disease 145
OBESITY REDUCES THE EXPRESSION OF GLUT4 IN THE ENDOMETRIUM OF NORMOINSULINEMIC WOMEN AFFECTED BY THE POLYCYSTIC OVARY SYNDROME 144
Ischemia-modified albumin in pregnancy. 143
Prediction of large-for-gestation neonates with first-trimester maternal serum PAPP-A 141
Genetic thrombophilias and uterine artery Doppler velocimetry and preeclampsia 141
L'aptoglobina: marker precoce di emolisi nella sindrome HELLP 140
Dal calcolo statistico alla sala parto: analisi del rischio di sproporzione cefalo pelvica e di ricorrere al tagli ocesareo 140
Validation of pelvic masses score (PMS) in the preoperative evaluation of adnexal masses 140
Assessment of placental vascularization using three dimensional power Doppler Ultrasound in normal fetuses and fetuses affected by fetal growth restriction (IUGR) 140
’Comparison of 24mg and 12mg single-course Betamethasone prophilaxis: a retrospective study 140
COMBINED INTRAUTERINE AND CERVICAL PREGNANCY DIAGNOSED IN THE 13TH GESTATIONAL WEEK: WHICH TYPE OF MANAGEMENT IS MORE FEASIBLE AND SUCCESSFUL? 140
Amniotic fluid studies in gestosis 139
Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study 139
Three dimensional power Doppler angiography of placenta in normal and growth restricted fetuses 139
Use of intramyometrial injection of prostaglandin F 2 alpha in the management of intractable hemorrhage due to uterine atony 138
Localized ovarian cancer: surgery plus chemotherapy 138
Comparision of Pelvic Masses Score (PMS) and Risk of Malignancy Index (RMI3) in the evaluation of Pelvic Masses 138
New and old predictive factors for breech presentation: our experience in 14 433 singleton pregnancies and a literature review. 138
Retrospective analysis of the management for impaired glucose tollerance during pregnancy 137
The diagnostic value of endoemetrial volume and vascularity measurements by transvaginal 3-dimensional ultrasonography and Power Doppler Angiography in patients with postmenopausal bleeding 137
Use of recombinant activated factor VII in severe post-partum haemorrhage: data from the Italian Registry: a multicentric observational retrospective study 137
Puerperal ovarian vein thrombosis: two case reports. PMID: 22890415 136
TROMBOFILIA CONGENITA E POLIABORTIVITA' 136
Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis 135
Totale 16.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021751 0 0 0 0 0 0 0 0 0 0 648 103
2021/20223.113 49 490 108 312 47 51 171 207 37 437 638 566
2022/20233.951 450 267 161 447 400 1.082 9 295 555 26 128 131
2023/20241.126 181 86 43 14 173 223 23 73 132 46 25 107
2024/20257.463 179 476 274 240 276 339 514 567 921 610 1.274 1.793
2025/202611.503 1.033 1.132 817 1.048 1.892 1.136 1.525 454 827 953 686 0
Totale 45.151